Location History:
- Düsseldorf, DE (2011 - 2013)
- Dusseldorf, DE (1998 - 2018)
Company Filing History:
2 out of 21 
1 out of 1,248 
1 out of 14,084 
Years Active: 1998-2018
Title: The Innovative Mind of Martin König: Advancements in Leukocyte Reduction Technology
Introduction
Martin König, an inventive mind based in Düsseldorf, Germany, has made significant contributions to the field of medical technology. With a strong background in innovations pertaining to blood treatment, his focus on leukocyte reduction has led to the development of two patented inventions that demonstrate his commitment to enhancing healthcare.
Latest Patents
König's latest patents include a "Method for the elimination of leukocytes from blood" and a "Device for removing leukocytes from blood." The first patent describes a unique method that reduces the number of leukocytes in blood by channeling it through a carefully arranged system of fibers made from organic polymers. This innovative approach facilitates the adsorption of leukocytes onto the fibers, thus allowing for a more efficient blood treatment process.
The second patent details a device comprising multiple hollow fibers arranged within a cylindrical housing. This device is engineered to ensure that only the external surfaces of the hollow fibers interact with the blood, while the internal lumina remain inaccessible. This design enhances the efficiency of leukocyte reduction while producing a significant level of the complement activation product C5a.
Career Highlights
König's career is marked by his collaboration with Membrana GmbH, where he has pushed the boundaries of medical innovation. His dual approach to leukocyte reduction, through both method and device, showcases his comprehensive understanding of biocompatible materials and their application in medical technology.
Collaborations
Throughout his career, Martin König has worked alongside talented professionals such as Horst-Dieter Lemke and Bodo Von Harten. This collaboration has fostered an environment of creativity and innovation, leading to advancements that impact patient care and broaden the understanding of leukocyte management in clinical settings.
Conclusion
In summary, Martin König's contributions to the field of medical technology through his inventions are paving the way for more effective treatments in managing blood components. With two patents under his name, his work at Membrana GmbH reflects a dedication to improving healthcare solutions, ultimately benefiting patients in need of advanced blood treatment methods.